Therapy Areas: Infectious Diseases
19 April 2018 - Motif Bio (LON: MTFB) will present new clinical and pre-clinical data for its investigational drug candidate iclaprim at the 28th European Congress of Clinical Microbiology and Infecti...
19 April 2018 - - Espoo, Finland-based molecular diagnostics company Mobidiag has launched Novodiag Bacterial GE+, a molecular diagnostic test for the simultaneous detection of most common enteric pat...
18 April 2018 - - Cambridge, Massachusetts-based RNA interference therapeutics developer Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has presented new results from the Phase 1 and Phase 1/2 open-labe...
16 April 2018 - - Exton, Pennsylvania-based clinical-stage biotechnology company Morphotek, Inc. has licensed its eribulin-linker payload to Hangzhou, China-based biopharmaceutical company Bliss Bioph...
12 April 2018 - - Exton, Pennsylvania-based clinical-stage biotechnology company Morphotek, Inc. has licensed its eribulin-linker payload to Hangzhou, China-based biopharmaceutical company Bliss Bioph...
10 April 2018 - - Berlin, Germany-based biopharmaceutical company Mologen AG's final evaluation of the randomized exploratory phase II IMPULSE study confirmed findings presented in April 2017 and...